MedPath

Efficacy of Lacosamide and Topiramate on Control of Neonatal Refractory Seizures

Phase 3
Completed
Conditions
eonatal Seizure.
Convulsions of newborn
Registration Number
IRCT20230415057911N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Neonates with seizure who did not respond to phenobarbital (dose40 mg/kg) and Levebel (40 mg/kg).
Infants under 3 months with refractory seizures whose seizures have started since infancy (under one month).
Seizures due to secondary abnormalities in asphyxia, brain structural disorders, familial seizures, congenital and acquired infections, vascular lesions

Exclusion Criteria

Seizures that started after neonatal Period
Seizures due to secondary abnormalities in metabolic disorders or electrolyte disorders.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.